Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurilemmoma × erenumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Schwannomatosis 1 Pain 1 Neurilemmoma 1 Chronic Pain 1

Interventions

tanezumab 1 siltuximab 1 erenumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Saline Solution 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1 Mn-PyC3A 1 Lapatinib 1 Hyperspectral Imaging 1 Bevacizumab 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684692 2025-10-30

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡